Uganda gets Ebola vaccine doses for trial on Sudan strain | Ap | #datingscams | #russianliovescams | #lovescams


KAMPALA, Uganda (AP) — Uganda’s government says it has received more than 5,000 doses of Ebola vaccines for a clinical trial to assess their protection against the Sudan strain of the virus that caused an outbreak with over 50 deaths.

Health Minister Jane Ruth Aceng told journalists on Thursday that a global expert consultation will be held on Jan. 12 to determine when the trials should start.


This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

kAm%92E’D 2 52J 27E6C E96 (@C=5 w62=E9 ~C82?:K2E:@? 😀 6IA64E65 E@ 564=2C6 E96 &82?52 @FE3C62< @G6C :7 ?@ ?6H 42D6D 2C6 C6A@CE65] p44@C5:?8 E@ (w~ 8F:56=:?6D[ 2? @FE3C62< 😀 564=2C65 @G6C :7 E96C6 2C6 ?@ ?6H :?764E:@?D H:E9:? ca 52JD]k^Am

kAm&82?52 92D C64@C565 `ca 42D6D :?4=F5:?8 de 562E9D D:?46 E96 t3@=2 @FE3C62< H2D 2??@F?465 😕 $6AE6>36C] %96 $F52? DEC2:? @7 E96 G:CFD[ F?=:<6 E96 +2:C6 DEC2:? E92E 92D 42FD65 @FE3C62<D 😕 ?6:893@C:?8 r@?8@ 😕 C646?E J62CD[ 92D ?@ AC@G6? G244:?6]k^Am

kAm%9:D @FE3C62<[ E96 7:CDE 😕 2 564256 @7 E96 =6DD 4@>>@? $F52? DEC2:?[ 😀 2 492?46 7@C 4=:?:42= EC:2=D @7 E96 E9C66 G244:?6D 5@?2E65 3J E96 &]$]\32D65 $23:? ‘244:?6 x?DE:EFE6[ &?:G6CD:EJ @7 ~I7@C5 2?5 |6C4<]k^Am

kAm&82?52’D 962=E9 >:?:DE6C D2:5 A2CE:4:A2E:@? 😕 E96 EC:2=D H:== 36 G@=F?E2CJ[ 2?5 E96 G244:?6D H:== ?@E 36 FD65 @FED:56 E96 EC:2=D]k^Am

kAm$96 E92?<65 E96 &]$][ qC:E:D9 2?5 r2?25:2? 8@G6C?>6?ED 2D H6== 2D :?E6C?2E:@?2= 286?4:6D =:<6 E96 (w~[ E96 w62=E9 t>6C86?4J 2?5 !C6A2C65?6DD 2?5 #6DA@?D6 pFE9@C:EJ 2?5 E96 r@2=:E:@? 7@C tA:56>:4 !C6A2C65?6DD x??@G2E:@?D 7@C 7F?5:?8 E96 EC:2= AC@46DD]k^Am

kAmt3@=2[ H9:49 42? D@>6E:>6D >2?:76DE 2D 2 96>@CC928:4 76G6C[ DAC625D E9C@F89 4@?E24E H:E9 E96 3@5:=J 7=F:5D @7 2? :?764E65 A6CD@? @C 4@?E2>:?2E65 >2E6C:2=D] %96 (@C=5 w62=E9 ~C82?:K2E:@? 92D D2:5 E96 72E2=:EJ C2E6 @7 E96 4FCC6?E @FE3C62< 😀 23@FE c_T]k^Am

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.



Click Here For The Original Source.

. . . . . . .